Derek T. Chalmers is CEO & President at Cara Therapeutics, Inc. (CARA). They have made 37 open-market trades across 1 company since 2016, most recently 2021-09-07.
CIK 0001166287
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 37 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CARA | 991,405 | $5.3M |
Shares reported on the most recent Form 4, priced at the 2021-09-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CARA | SELL | 2021-09-07 | 2021-09-09 | $15.47 | $309K | +0.0% | -10.4% | -17.9% |
| CARA | SELL | 2021-08-30 | 2021-09-01 | $14.20 | $120K | -8.6% | -4.7% | -17.6% |
| CARA | SELL | 2021-03-05 | 2021-03-08 | $17.98 | $112K | +5.8% | +46.7% | -25.5% |
| CARA | SELL | 2021-02-25 | 2021-02-25 | $19.33 | $453K | -5.3% | +1.5% | -30.9% |
| CARA | SELL | 2020-12-30 | 2020-12-30 | $15.30 | $186K | +11.5% | +22.0% | +34.3% |
| CARA | SELL | 2020-12-28 | 2020-12-29 | $16.00 | $80K | +7.3% | +20.8% | +30.7% |
| CARA | SELL | 2020-12-16 | 2020-12-18 | $14.95 | $75K | +2.0% | +35.3% | +28.9% |
| CARA | SELL | 2020-12-10 | 2020-12-11 | $15.29 | $115K | +4.5% | +9.3% | +29.5% |
| CARA | SELL | 2020-11-17 | 2020-11-19 | $16.00 | $189K | -5.5% | -5.2% | +33.7% |
| CARA | SELL | 2020-09-03 | 2020-09-08 | $16.00 | $51K | -6.7% | -9.4% | -3.7% |
| CARA | SELL | 2020-08-03 | 2020-08-05 | $16.42 | $164K | -1.2% | -10.9% | -23.0% |
| CARA | SELL | 2020-07-01 | 2020-07-02 | $17.11 | $86K | +1.3% | -3.1% | -28.1% |
| CARA | SELL | 2020-06-01 | 2020-06-03 | $16.01 | $80K | -2.7% | +10.2% | -5.5% |
| CARA | SELL | 2020-05-20 | 2020-05-22 | $16.00 | $81K | -6.8% | +3.4% | -2.5% |
| CARA | SELL | 2020-05-12 | 2020-05-14 | $16.00 | $79K | +7.1% | +3.5% | +13.4% |
| CARA | SELL | 2020-04-21 | 2020-04-21 | $15.56 | $198K | -12.1% | -1.7% | +10.2% |
| CARA | SELL | 2020-01-02 | 2020-01-06 | $16.05 | $161K | +10.8% | +11.4% | -12.1% |
| CARA | SELL | 2019-12-02 | 2019-12-04 | $19.83 | $623K | +1.2% | -10.5% | -11.8% |
| CARA | SELL | 2019-11-01 | 2019-11-05 | $20.79 | $104K | +4.7% | -20.2% | -19.3% |
| CARA | SELL | 2019-10-01 | 2019-10-03 | $18.28 | $183K | +1.7% | +7.0% | -19.0% |
| CARA | SELL | 2019-09-03 | 2019-09-05 | $23.26 | $233K | +1.1% | -18.9% | -27.4% |
| CARA | SELL | 2019-08-01 | 2019-08-05 | $23.27 | $233K | +0.7% | +2.2% | -9.3% |
| CARA | SELL | 2019-05-29 | 2019-05-30 | $21.42 | $237K | -5.4% | +6.8% | +9.8% |
| CARA | SELL | 2019-03-01 | 2019-03-05 | $17.04 | $334K | +10.3% | +17.6% | +21.4% |
| CARA | SELL | 2019-02-01 | 2019-02-05 | $14.99 | $300K | +8.1% | +3.7% | +27.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.